Dr. Gary Raskob's research and scholarly interests are in the prevention, diagnosis and treatment of deep-vein thrombosis and pulmonary embolism; the clinical development of antithrombotic drugs; clinical trials; prevention research; evidence-based medicine; and the translation of research evidence into practice and health policy.
Dr. Raskob has participated extensively in clinical practice guideline development for several specialty organizations including the American Society of Hematology, the American College of Chest Physicians, the American Thoracic Society, and the American Society of Clinical Oncology. He also serves as an advisor on thrombosis and hemostasis for the U.S. National Heart, Lung, and Blood Institute, and the Centers for Disease Control and Prevention. Dr. Raskob is author or coauthor of more than 200 publications on the prevention, diagnosis and treatment of thromboembolic disease, including 16 articles in the New England Journal of Medicine.
Dr. Gary Raskob, Dean of the College of Public Health at the University of Oklahoma Health Sciences Center, and Chairman of WTD Steering Committee